Atlas Trials

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

Clinical trial NCT04711265 · COMPLETED

Trial details

NCT number
NCT04711265
Sponsor
Kenya Medical Research Institute
Status
COMPLETED
Study type
OBSERVATIONAL
HPV VaccineHPV InfectionHIV-1-infection
Start date
2015-09-01
Primary completion
2018-11-01
Enrollment
176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.